Here is What Hedge Funds Think About BioMarin Pharmaceutical Inc. (BMRN)
Before we spend countless hours researching a company, we’d like to analyze what insiders, hedge funds and billionaire investors think of the stock......(read more)
Posts Tagged ‘NASDAQ:BMRN’
Were Hedge Funds Right About BioMarin Pharmaceutical Inc. (BMRN) ?
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients’ money after undertaking a rigorous examination......(read more)
Argentiere Capital’s Returns, AUM and Holdings
Deepak Gulati‘s Argentiere Capital is a Zug, Switzerland-based hedge fund launched back in June 2013, with an additional office in Chicago. The......(read more)
Here is What Hedge Funds Think About BioMarin Pharmaceutical Inc. (BMRN)
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which......(read more)
Hedge Funds Are Buying BioMarin Pharmaceutical Inc. (BMRN)
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns. Hedge......(read more)
Palo Alto Investors’s Bets on ABIOMED, Inc. (ABMD), United Therapeutics Corporation (UTHR) and Other Stocks Lift Its Q3 Returns
Palo Alto Investors was founded by William Leland Edwards in 1989. The fund usually invests in companies with market capitalization less than $3 billion......(read more)
Catalyst Pharmaceuticals Inc (CPRX) Isn’t Out Of The Woods With Firdapse Just Yet
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) just announced that it is carrying forward with a special protocol assessment (SPA) for its lead asset, Firdapse......(read more)
10 Most Successful Innovative Companies in The World in 2016
Which are the most successful innovative companies in the world in 2016? Bringing something new to the table is something that seems to be difficult these......(read more)
A Look At The Science Behind BioMarin Pharmaceutical Inc. (BMRN)’s Next Pivotal Candidate
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) just put out an update relating to its lead achondroplasia asset, Vosoritide, and the company is up a couple......(read more)
Blue Jay Capital Betting On Big Returns From These Healthcare Stocks
Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California. Prior to founding Blue Jay......(read more)
BioMarin Pharmaceutical Inc. (BMRN)’s Setback Isn’t Really A Setback
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) just announced that the FDA has delayed its PDUFA for the companies lead Batten Disease candidate, meaning......(read more)
Thursday’s Top Trending Tickers: MSFT, VOD, LB, BMRN, GLW
The U.S stock market is green across the board as positive reigns ahead of crucial jobs data to be announced tomorrow. Some of the stocks that investors......(read more)
Why Traders Are Buzzing About MGM, Apple, and Three Other Companies Today
Although crude futures are well in the green, the three indexes have opened in the red on Friday. The Dow and S&P 500 are off by 0.2% while the NASDAQ......(read more)
Mariner Investment’s Top Healthcare Picks
Among some 800 hedge funds we track at Insider Monkey, we seldom come across funds that specialize in investing in a particular sector or have a penchant......(read more)
Palo Alto’s Top Picks for This Year Following Impressive 2015 Returns
William Leland Edwards‘ Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management. According to our calculations......(read more)
Top Stock Picks of Multi-Billion Dollar, Healthcare-Focused Fund Palo Alto Investors
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States......(read more)
New Additions Highlight Kyle Bass’ Top Stock Picks for Q4
Kyle Bass of Hayman Advisors is one investment manager with great cachet, which includes having a chapter dedicated to him in Michael Lewis’ post......(read more)
Is BioMarin Pharmaceutical Inc. (BMRN) A Good Stock To Buy?
Between June 25 and October 30th the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 14 percentage points as investors worried......(read more)
BioMarin Pharmaceutical Inc. (BMRN) Surges But Is It A Good Stock To Buy Now?
Is BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) a good stock to buy now? Shares of the company are surging today after the pharmaceutical firm revealed......(read more)
Endo International plc (ENDP), BioMarin Pharmaceutical Inc. (BMRN): Visium Picks Returned 13% but Net Returns Were Only 5% – Here’s Why
The broad portfolio of Jacob Gottlieb’s Visium Asset Management enjoyed a very strong quarter, with the weighted average returns of its 817 reported......(read more)
Billionaire John Griffin’s Five Picks That Killed the Market This Quarter
John Griffin’s Blue Ridge Capital had a great start to the year, as its 45 long positions in stocks with a market cap above $1.0 billion returned 6.......(read more)
Era Group Inc (ERA), BioMarin Pharmaceutical Inc. (BMRN), & Assured Guaranty Ltd. (AGO) Among Stocks Amici Capital Is Bullish on
Paul Orlin‘s Amici Capital has increased its exposure to Era Group Inc (NYSE:ERA), as a new filing with the Securities and Exchange Commission......(read more)
Palo Alto Rejoicing at ABIOMED, Inc. (ABMD)’s 18% Spike
ABIOMED, Inc. (NASDAQ:ABMD) spiked as high as 21% in Tuesday’s intraday trading to eventually close at 18% in the green at $72.48. The rise came......(read more)
BioMarin Pharmaceutical Inc. (BMRN) and Other Top New Picks of Healthcare-Focused Visium Asset Management
Jacob Gottlieb‘s Visium Asset Management has recently revealed its equity positions as of the end of the fourth quarter in a 13F filing with the......(read more)
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio. One of the companies involved......(read more)
Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)
As fast as we can type this, Phill Gross and Robert Atchinson’s hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares......(read more)
Should You Buy Regeneron Pharmaceuticals Inc (REGN)?
Is Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a good investment? If you were to ask many investors, hedge funds are viewed as delayed, outdated investment......(read more)
AstraZeneca plc (ADR) (AZN), Bristol-Myers Squibb Co (BMY), BioMarin Pharmaceutical Inc. (BMRN): Three PDUFA Dates That Will Kick Off 2014
The phrase “PDUFA date” is thrown around frequently when discussing biotech and pharma companies. PDUFA stands for the Prescription Drug User......(read more)
What Hedge Funds Think About Vertex Pharmaceuticals Incorporated (VRTX)
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) a buy? In the 21st century investor’s toolkit, there are tons of metrics market participants can......(read more)
Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors: listen up. In the 21st century investor’s toolkit, there are tons of metrics shareholders can use......(read more)
Do Hedge Funds and Insiders Love Alexion Pharmaceuticals, Inc. (ALXN)?
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) investors are standing pat. In the 21st century investor’s toolkit, there are dozens of indicators investors......(read more)
Hedge Funds Are Crazy About BioMarin Pharmaceutical Inc. (BMRN)
Should you be crazy about BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)? In the financial world, there are dozens of gauges shareholders can use to analyze......(read more)
Is Illumina, Inc. (ILMN) Going to Burn These Hedge Funds?
If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times. Although there are more......(read more)
Incyte Corporation (INCY), BioMarin Pharmaceutical Inc. (BMRN): Two Biotech Stocks That Could Be on Novartis AG (ADR) (NVS)’s Buyout Radar
The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is really beginning to heat up, and it’s offering investors......(read more)
Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): 5 of the World’s Most Ultra-Rare Diseases
There are few times when your doctor or physician will utter the phrase, “I don’t know” to a patient, but when you’re dealing......(read more)
Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), BioMarin Pharmaceutical Inc. (BMRN): Orphan Drug Makers – Robust Investment Opportunities
The US pharmaceutical industry has been revolutionized by the emerging biotech companies which have discovered new ways to cure even the rarest of diseases......(read more)
Alexion Pharmaceuticals, Inc. (ALXN), Eli Lilly & Co. (LLY): Five Drugmakers With a Lot on the Line
You may or may not have heard, but it’s earnings season again. Contrary to popular belief, earnings season does actually take a break for a few......(read more)
Exploding Pipeline Makes BioMarin Pharmaceutical Inc. (BMRN) Attractive Takeover Target
The Orphan Drug pipeline of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has been growing so rapidly that the company has been the object of many takeover......(read more)
LinkedIn Corp (LNKD), BioMarin Pharmaceutical Inc. (BMRN), ArcelorMittal (ADR) (MT): Don’t Miss These Three Companies With High Earnings-Per-Share Forecasts
Earnings per share, or EPS, is an important metric for investors performs a lot of functions: It helps suggest potential profits on individual shares......(read more)
Wells Fargo & Co (WFC), Baxter International Inc. (BAX): Obamacare-Inspired Investment Opportunities
Love it or hate it, the Patient Protection and Affordable Care Act — commonly referred to as Obamacare — changes the health care landscape......(read more)
Dendreon Corporation (DNDN), Johnson & Johnson (JNJ), Medivation Inc (MDVN): The Most Expensive Drugs in the World
The prescription-drug market currently generates a whopping $950 billion in annual sales, and that figure is likely to grow to $1.2 trillion by 2016.......(read more)
Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): What Makes a Good Orphan Drug Investment?
Orphan drug companies are an exciting new class in the healthcare sector — with good and bad investment opportunities — let’s look at......(read more)
Highlights from the Goldman Sachs Group Inc (GS) Healthcare Conference
Goldman Sachs Group Inc (NYSE:GS) recently hosted its 34th Annual Global Healthcare Conference on June 11 – 13 in Rancho Palos Verdes, CA. Healthcare......(read more)
Clovis Oncology Inc (CLVS), Synta Pharmaceuticals Corp. (SNTA): Post-ASCO Movers – Are Any a Buy?
Late last year, Clovis Oncology Inc (NASDAQ:CLVS) saw its share price cut in half, to $11.50, after reporting that its Phase 3 drug CO-101 failed to show......(read more)
Clovis Oncology Inc (CLVS): Double Data, Double Stock Price
Plenty of data was presented at the American Society for Clinical Oncology meeting over the weekend, causing the first set of ASCO pops, but Clovis Oncology......(read more)
Hedge Funds Are Selling BioMarin Pharmaceutical Inc. (BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) was in 22 hedge funds’ portfolio at the end of the first quarter of 2013. BMRN has experienced a decrease......(read more)
Alexion Pharmaceuticals, Inc. (ALXN), Vertex Pharmaceuticals Incorporated (VRTX): Orphan Drug Biotechs Do It Best
There are many biotech stocks to choose from that have long-lasting value. Each one can potentially have huge value, but there is a group of biotech stocks......(read more)
Hedge Funds Are Selling BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) was in 24 hedge funds’ portfolio at the end of December. BMRN investors should be aware of a decrease......(read more)
Analyst Roundtable: Any Surprises in Amarin Corporation plc (ADR) (AMRN)’s Fourth Quarter?
Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to discuss Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a biotech......(read more)
4 Orphan Drugs Making Waves in 2013: Sanofi SA (ADR) (SNY) and More
Orphan drugs — medications meant for small patient populations with rare, dangerous diseases — can be a rewarding business for biotech firms......(read more)
